Performance of the Minto model for the target-controlled infusion of remifentanil during cardiopulmonary bypass
Anaesthesia Sep 14, 2017
Cho YJ, et al. - This study examined the predictive performance of the Minto pharmacokinetic model for remifentanil target-controlled infusion during cardiopulmonary bypass in patients undergoing cardiac surgery. Despite showing considerable bias, the Minto model displayed overall acceptable precision during bypass and when using this model during hypothermic circulatory arrest, the target concentration of remifentanil should be reduced.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries